Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This ...

This is impractical since they charge $100+ to come to your house. Despite the fact that the lawn mower cost more than $3000 dollars the company is too cheap to reimburse me for a $50 battery.

Lawyers for a man charged with the murder of his wife – who was allegedly found dead near a ride-on mower – have told a court of the next step they will take. Robert John Crawford, 47 ...

Turner, who passed away at 76, was hurt last month when he plummeted into an empty swimming pool while riding a lawn mower, the Associated Press reported. "Johnnie spent his life lifting others ...

John Titta, ASCAP’s chief creative officer and a veteran music executive, has died after a two-year battle with cancer, a rep for the organization confirms. “All of us at ASCAP are heartbroken ...

After 44 days, Kendric Cromer, the world’s first sickle cell patient to start commercially licensed gene therapy, was finally discharged from the hospital last Wednesday. One study estimates ...

Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans ...

Editas Medicine said Tuesday it will license out or partner its lead sickle cell treatment, the latest shift for a tarantella company that has repeatedly switched direction and leadership since ...

A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct. 21. Kendric Cromer began treatment with Bluebird bio's ...

Agri-Pulse’s Noah Wicks reported that “the investigation’s reveal comes more than two years after the National Farmers Union, along with six of its state-level affiliates and five ‘right to repair’ ...

Staff lined the hallway, cheering and waving noisemakers. He had just become the first patient to receive a gene therapy for sickle cell since it was approved — a therapy that is expected to ...